Cancer Start-Up GRAIL Added One of Silicon Valley’s Best-Known Biotech VCs to Its Board
Grail, a company working to develop “liquid biopsies” for spotting cancer in the earliest stages, recently announced that it has added venture capitalist Brook Byers to its board of directors, according to an SEC filing. The filing also showed that Grail has raised a total of $973 million in its current Series B funding round. The company is now just shy of its goal to raise over $1 billion in this round of investment. Grail plans to use the capital for research and development, as well...